Cargando…

Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?

Detalles Bibliográficos
Autores principales:	Mitnick, Carole D., Nunn, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595440/ https://www.ncbi.nlm.nih.gov/pubmed/36952239 http://dx.doi.org/10.1164/rccm.202303-0430ED

Ejemplares similares

Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines
por: Hourihane, Jonathan O’B., et al.
Publicado: (2021)

How imputation can mitigate SNP ascertainment Bias
por: Geibel, Johannes, et al.
Publicado: (2021)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies
por: Rohlwink, Ursula K, et al.
Publicado: (2020)

Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial
por: Solans, Belén P, et al.
Publicado: (2023)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
por: Fanaroff, Alexander C., et al.
Publicado: (2020)

Ascertainment bias from imputation methods evaluation in wheat
por: Brandariz, Sofía P., et al.
Publicado: (2016)

Resolving kangaroo phylogeny and overcoming retrotransposon ascertainment bias
por: Dodt, William G., et al.
Publicado: (2017)

How array design creates SNP ascertainment bias
por: Geibel, Johannes, et al.
Publicado: (2021)

Ascertainment bias in the genomic test of positive selection on regulatory sequences
por: Jiang, Daohan, et al.
Publicado: (2023)

The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
por: Phillips, Patrick PJ, et al.
Publicado: (2011)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

Detecting and Removing Ascertainment Bias in Microsatellites from the HGDP-CEPH Panel
por: Eriksson, Anders, et al.
Publicado: (2011)

Adjusting heterogeneous ascertainment bias for genetic association analysis with extended families
por: Park, Suyeon, et al.
Publicado: (2015)

Role of Ascertainment Bias in Determining Case Fatality Rate of COVID-19
por: Smith, Maia P.
Publicado: (2021)

The End TB Strategy: India can blaze the trail
por: Pai, Madhukar
Publicado: (2015)

Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses
por: Brooks, Meredith B., et al.
Publicado: (2020)

Can mathematical modelling solve the current Covid-19 crisis?
por: Panovska-Griffiths, Jasmina
Publicado: (2020)

Pathology assessment is necessary to validate translational endpoints in preclinical aging studies
por: Ladiges, Warren
Publicado: (2016)

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities
por: Roy-Chaudhury, Prabir
Publicado: (2017)

Can DOT improve treatment-seeking behavior of TB patients?
por: Paliwal, Rajiv
Publicado: (2010)

Impact of Marker Ascertainment Bias on Genomic Selection Accuracy and Estimates of Genetic Diversity
por: Heslot, Nicolas, et al.
Publicado: (2013)

Ascertainment Bias in a Historic Cohort Study of Residents in an Asbestos Manufacturing Community
por: Wortzel, Jeremy D., et al.
Publicado: (2021)

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
por: Phillips, Patrick P. J., et al.
Publicado: (2019)

The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021)

Modeling of African population history using f-statistics can be highly biased and is not addressed by previously suggested SNP ascertainment schemes
por: Flegontov, Pavel, et al.
Publicado: (2023)

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?
por: Otte, Julie L, et al.
Publicado: (2015)

Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
por: Prasad, Rajendra, et al.
Publicado: (2022)

Nighttime Acid Reflux in Gastroesophageal Reflux Disease - Is It a Problem That Can Be Solved?
por: Choi, Yonghoon, et al.
Publicado: (2023)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

Discovery of novel variants in genotyping arrays improves genotype retention and reduces ascertainment bias
por: Didion, John P, et al.
Publicado: (2012)

Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different
por: LaHood, Allison, et al.
Publicado: (2022)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

Measurement of intragastric pressure: an objective method to ascertain whether gastric wall extension is sufficient for assessment of the non-extension sign
por: Imamura, Kentaro, et al.
Publicado: (2021)

Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
por: McDonald, James, et al.
Publicado: (2023)

How Can We Solve the Enigma of Influenza Vaccine–Induced Protection?
por: Neuzil, Kathleen M.
Publicado: (2015)

An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse
por: Phillips, Patrick P. J., et al.
Publicado: (2013)

Efficiency of different strategies to mitigate ascertainment bias when using SNP panels in diversity studies
por: Malomane, Dorcus Kholofelo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9j8524ue0kn7u3a1rie208as94